Changing epidemiology of nasopharyngeal carcinoma in Hong Kong over a 20‐year period (1980–99): An encouraging reduction in both incidence and mortality

Epidemiological data from the Hong Kong Cancer Registry for the period 1980–99 were analyzed. Altogether 21,768 new cases of nasopharyngeal carcinoma (NPC) and 8,664 related deaths were registered. In both genders, the peak incidence occurred in the 50–59 years age group, and this age distribution pattern remained similar throughout. The age‐standardized incidence rate steadily decreased from 28.5 in 1980–84 to 20.2 in 1995–99 per 100,000 males, and from 11.2–7.8 per 100,000 females, resulting in a total decrease of 29% for males and 30% for females over this 20‐year period. The magnitude of total decrease in NPC mortality amounted to 43% and 50%, respectively, as the age‐standardized mortality rate steadily decreased from 13.7 in 1980–84 to 7.8 in 1995–99 per 100,000 males, and from 4.5–2.2 per 100,000 females. The age‐standardized mortality/incidence ratio also decreased from the peak of 0.48 in 1980–84 to 0.39 in 1995–99 for males, and from 0.40–0.29 for females. Females had significantly lower age‐standardized incidence (male/female ratio 2.5–2.6, p < 0.01) and mortality (male/female ratio 3.0–3.5, p< 0.01) throughout the whole period. Furthermore, females had consistently lower mortality/incidence ratio: 0.29 vs. 0.39 in 1995–99. These data are highly suggestive of significant improvement in prevention and control of NPC in Hong Kong. Closer scrutiny of the differences in intrinsic and extrinsic factors between the genders might help to show important factors affecting oncogenesis and prognosis. Possible ways for further reduction of incidence and mortality are discussed. © 2002 Wiley‐Liss, Inc.

[1]  C. Heath,et al.  Nasopharyngeal cancer in Bermuda , 1976, Cancer.

[2]  M. Yu,et al.  Nasopharyngeal carcinoma: epidemiology and dietary factors. , 1991, IARC scientific publications.

[3]  M. Ng,et al.  Epstein-Barr-virus-specific IgA and IgG serum antibodies in nasopharyngeal carcinoma. , 1976, British Journal of Cancer.

[4]  Y. F. Poon,et al.  Retrospective analysis of 5037 patients with nasopharyngeal carcinoma treated during 1976-1985: overall survival and patterns of failure. , 1992, International journal of radiation oncology, biology, physics.

[5]  B. Henderson,et al.  Occupational and other non‐dietary risk factors for nasopharyngeal carcinoma in Guangzhou, China , 1990, International journal of cancer.

[6]  D. Choy,et al.  Nasopharyngeal carcinoma---time lapse before diagnosis and treatment. , 1998, Hong Kong medical journal = Xianggang yi xue za zhi.

[7]  N. Day,et al.  HLA and nasopharyngeal carcinoma in chinese —A further study , 1983, International journal of cancer.

[8]  D. Qin,et al.  Analysis of 1379 patients with nasopharyngeal carcinoma treated by radiation , 1988, Cancer.

[9]  J. Meyer,et al.  Carcinoma of the nasopharynx. Factors influencing results of therapy. , 1971, Radiology.

[10]  J. Ferlay,et al.  Cancer Incidence in Five Continents , 1970, Union Internationale Contre Le Cancer / International Union against Cancer.

[11]  H. King,et al.  Cancer mortality among foreign- and native-born Chinese in the United States. , 1973, Journal of chronic diseases.

[12]  Salted Fish and Nasopharyngeal Carcinoma , 1989, The Lancet.

[13]  P. Buell The effect of migration on the risk of nasopharyngeal cancer among Chinese. , 1974, Cancer research.

[14]  T. Bender,et al.  Nasopharyngeal carcinoma in an Alaskan Eskimo family: report of three cases. , 1979, Journal of the National Cancer Institute.

[15]  S. Nevo,et al.  Carcinoma of nasopharynx in twins , 1971, Cancer.

[16]  W. Henle,et al.  Presence of EBNA in nasopharyngeal carcinoma and control patient tissues related to ebv serology , 1978, International journal of cancer.

[17]  W. Henle,et al.  Epstein‐barr virus‐specific IgA serum antibodies as an outstanding feature of nasopharyngeal carcinoma , 1976, International journal of cancer.

[18]  Huang Shu-chen,et al.  Nasopharyngeal cancer: a review of 1605 patients treated radically with cobalt 60. , 1980, International journal of radiation oncology, biology, physics.

[19]  G. Swanson,et al.  Associations between human leukocyte antigen type and nasopharyngeal carcinoma in Caucasians in the United States. , 1996, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[20]  W. D. Stinson,et al.  XXXIX Epidermoid Carcinoma of the Nasopharynx Occurring in Two Young Brothers , 1940 .

[21]  R. W. Armstrong,et al.  Salted fish and inhalants as risk factors for nasopharyngeal carcinoma in Malaysian Chinese. , 1983, Cancer research.

[22]  D. Choy,et al.  Prognostic factors of nasopharyngeal carcinoma: a review of 759 patients. , 1990, The British journal of radiology.

[23]  H. Bartsch,et al.  Volatile nitrosamine levels in common foods from tunisia, south china and greenland, high‐risk areas for nasopharyngeal carcinoma (NPC) , 1987, International journal of cancer.

[24]  S. C. Huang Nasopharyngeal cancer: a review of 1605 patients treated radically with cobalt 60. [5- and 10-year survival rates and complications of radiotherapy] , 1980 .

[25]  G. de Thé The etiology of nasopharyngeal carcinoma. , 1972, Pathobiology annual.

[26]  Jian-Min Yuan,et al.  Epidemiology of nasopharyngeal carcinoma. , 2002, Seminars in cancer biology.

[27]  W. Taylor,et al.  Prognostic Determinants and a New View of Staging for Patients with Nasopharyngeal Carcinoma , 1985, The Annals of otology, rhinology, and laryngology.

[28]  S. Chan Aetiology of Nasopharyngeal Carcinoma , 1976, The Lancet.

[29]  S. Leung,et al.  Significant prognosticators after primary radiotherapy in 903 nondisseminated nasopharyngeal carcinoma evaluated by computer tomography. , 1996, International journal of radiation oncology, biology, physics.

[30]  Huang Dp Epidemiology of nasopharyngeal carcinoma. , 1990 .

[31]  Y. F. Poon,et al.  Nasopharyngeal carcinoma: presenting symptoms and duration before diagnosis. , 1997, Hong Kong medical journal = Xianggang yi xue za zhi.

[32]  N. Day,et al.  PROBABLE IDENTIFICATION OF AN HL-A SECOND-LOCUS ANTIGEN ASSOCIATED WITH A HIGH RISK OF NASOPHARYNGEAL CARCINOMA , 1975, The Lancet.